The world-wide spread of the new coronavirus is throwing into disarray studies critical to the development of promising new medicines.

The pandemic is causing delays in starting clinical drug trials and temporarily halting others, according to companies, consultants and industry officials. Patients enrolled in some studies have stopped showing up at trial sites, while hospitals supposed to see trial subjects are shifting attention to tackling coronavirus patients. Industry scientists, meanwhile, can’t travel for research.

Read More